<DOC>
	<DOCNO>NCT00475605</DOCNO>
	<brief_summary>This observational study ass long-term safety Protopic® Ointment treatment atopic dermatitis . Patients whose age are/were &lt; 16 year time first tacrolimus ointment exposure eligible participate . No drug distribute observational trial .</brief_summary>
	<brief_title>A Pediatric Longitudinal Evaluation Assess Long-Term Safety Protopic Treatment Atopic Dermatitis</brief_title>
	<detailed_description>Data collect enrollment every 6 month thereafter either interview , Internet , physician office visit . Each subject follow 10 year study .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Subjects first use Protopic® 0.03 % 0.1 % sixteen year age treat least 6 week treatment Atopic dermatitis may enroll study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>atopic dermatitis</keyword>
	<keyword>child</keyword>
	<keyword>tacrolimus ointment</keyword>
	<keyword>Protopic Ointment</keyword>
</DOC>